Adipofill’in™ (Ornithine, Phospholipids & Glycolipids): A clinically tested biotech complex that helps support natural-looking volume in areas that may appear hollow or deflated, like cheeks and smile lines.*
Centella Asiatica Exosomes: Ultra-pure, plant-derived “messenger molecules” that help support collagen and elastin, improving the look of elasticity, resilience, and firmness.†
ChroNOline™ Peptide (Caprooyl Tetrapeptide-3): A clinically shown peptide that helps reduce the appearance of fine lines and wrinkles while supporting firmer, smoother-looking skin.§
SenePlex+®‡: A clinically proven proprietary complex shown to accelerate skin renewal, helping boost hydration, radiance, and overall skin performance.‡
Glycerin: A moisture-attracting humectant that hydrates and helps lock in softness.
Scent: A subtle, floral-inspired fragrance.
*Based on independent ingredient-level testing. In a 60-day split-face clinical (n=20; ages 40–60), the Adipofill’in™ side showed improved appearance of nasolabial folds and skin smoothness, with instrumental measures at 30 days indicating -9.5% wrinkle depth and -5.9% skin roughness vs. baseline/placebo. This is not a SeneGence clinical study. Individual results may vary.
† Clinical studies on plant-derived exosome technology show improvements in skin texture, fullness, and overall appearance. These vesicles help support natural cell-to-cell communication, which can enhance skin hydration, smoothness, and visible radiance.These are not SeneGence clinical studies. Individual results may vary.
‡ SenePlex+® clinically proven to accelerate skin cell renewal by 100% in just 18 days—twice the normal rate of the skin’s 28-day cycle. Based on 20-Day independent clinical study of thirty-three participants, women ages 19 to 65. Results are measured by expert clinical graded analysis compared to baseline.
§ Based on independent ingredient-level testing only. ChroNOline™ (Tetrapeptide-3) Clinically proven peptide that visibly reduces fine lines and wrinkles by up to 29% in 4 weeks and even tackles deep wrinkles with continued use. Based on a ChroNOline™ 56-day double-blind clinical trial of 27 women ages 40–65, with results measured against placebo. This is not a SeneGence clinical study.
All Trademarks are property of their respective owners.
